#United States #Minnesota #GammaTile #GT Medical Technologies #M Health Fairview

GT Medical Technologies Celebrates New GammaTile Center of Excellence Designation

GT Medical Technologies, a pioneer in innovative treatments for brain tumors, has recently designated M Health Fairview University of Minnesota Medical Center as a GammaTile Center of Excellence. This designation reflects the hospital's outstanding leadership in both patient education and the clinical implementation of the GammaTile procedure.

Founded in response to the growing needs of brain tumor patients, GT Medical Technologies focuses on enhancing treatment pathways and improving patient outcomes. The GammaTile device, which was introduced to the medical community in 2020, has revolutionized the treatment modalities available for brain tumors. By providing immediate, targeted radiation therapy during surgery, GammaTile minimizes the risks associated with traditional methods, where patients often face significant delays between surgical intervention and radiation treatment.

What is GammaTile?

GammaTile is a bioabsorbable device embedded with radiation seeds that are surgically implanted at the site of tumor removal. This unique approach allows it to deliver localized radiation treatment directly to the tumor site when cancer cells are most vulnerable immediately after surgery. Conventional treatments typically require a waiting period for healing before patients can begin radiation therapy, leaving them at risk for cancer recurrence during this crucial time.

In contrast, GammaTile's implantation offers an unprecedented method of targeting residual cancer cells while simultaneously safeguarding surrounding healthy brain tissue from unnecessary radiation exposure. As a result, the immediate use of radiation is designed to significantly increase the efficacy against remaining tumor cells and lower the likelihood of regrowth.

Recognition of Clinical Excellence

The GammaTile Center of Excellence designation is awarded to institutions and physicians that have shown exceptional skill and understanding in administering this procedure. For M Health Fairview, this recognition acknowledges not only its technical proficiency but also the commitment to ongoing education and maintaining high clinical standards. As part of the bid for this honor, physicians must meet stringent clinical criteria, including case volume and training, ensuring that they remain at the forefront of innovative treatment techniques.

The team at M Health Fairview includes notable figures in the field, such as:

• - Lindsey Sloan, MD, PhD: Radiation Oncologist
• - Andrew Venteicher, MD, PhD: Neurosurgeon
• - Daniel Guillaume, MD, MS: Neurosurgeon
• - Robert McGovern III, MD: Neurosurgeon
• - Matthew Hunt, MD: Neurosurgeon
• - Elizabeth Neil, MD: Neuro-Oncologist

Dr. Lindsey Sloan remarked, "As the first institution to implant GammaTiles, our designation as a Center of Excellence highlights our persistent dedication to enhancing brain tumor care. Targeted radiation therapy simplifies treatment post-surgery and helps to reduce the risk of recurrence while preserving healthy tissue."

Expanding Treatment Accessibility

Since its launch, GammaTile has experienced widespread adoption, with over 100 medical centers incorporating this innovative treatment into their surgical protocols. This acceptance underlines a significant shift in how brain tumors are being treated across various healthcare settings. The growing recognition of this technology underscores the increasing demand for focused, patient-centric treatment options that improve patient outcomes.

GT Medical Technologies, committed to advancing brain tumor management, has also established itself as a crucial resource in the fight against brain tumors, emphasizing both innovation and accessibility in patient care. As it continues to refine its offerings and partner with exceptional healthcare professionals, GT Medical Technologies remains dedicated to setting new standards in the treatment of brain conditions.

For more information regarding GammaTile technology and GT Medical Technologies, please visit gammatile.com or follow them on social media platforms including Facebook, Instagram, LinkedIn, and X. The future of brain tumor treatment looks promising as more centers come on board to embrace this cutting-edge approach, ensuring patients receive the most effective care available.